MarginProbe® Reduces the Rate of Re-Excision Following Breast Conserving Surgery for Breast Cancer

By DAY Vision | August 6, 2016

[vc_row][vc_column][vc_column_text]Jens-Uwe Blohmer1,2 • Julia Tanko2 • Janina Kueper1 • Jessica Groß1,2 • Ragna Volker1,2 • Anna Machleidt1,2 Anna Machleidt: [email protected] 1 Breast Center, Charite ́-Universita ̈tsmedizin Berlin, Charite ́platz 1, 10117 Berlin, Germany 2 Department of Gynecology and Breast Center, Sankt-Gertrauden Hospital, Paretzer Str. 12, 10713 Berlin, Germany Abstract Purpose A positive margin status after breast conserving surgery (BCS)…

Read More

First Patients Enrolled in United Kingdom’s National Health Service Sponsored Clinical and Economic Study of Using MarginProbe® During Breast Surgeries

By DAY Vision | June 21, 2016

[vc_row][vc_column][vc_column_text] 18-month study to be conducted across the U.K will look at the health, cosmetic and financial impact of MarginProbe margin assessment device for lumpectomy patients Paoli, PA, June 21, 2016 – Dilon Devices announced today that the first patients have been enrolled in a United Kingdom’s National Institute of Health Research (NIHR) subdivision of…

Read More

New Study Confirms MarginProbe® Demonstrates a 51% Reduction in Re-Excision Procedures

By DAY Vision | February 29, 2016

[vc_row][vc_column][vc_column_text] Ductal invasive cancer patients saw 89.8 percent reduction in re-excisions in a 322 patient prospective study Paoli, PA, Feb. 29, 2016 – New research lead by Professor Jens-Uwe Blohmer, director of the department of gynecology and the breast center of the Charité, Charité – Universitätsmedizin Berlin, demonstrates that proper use of MarginProbe, the first…

Read More